Literature DB >> 10838456

Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura.

E Bar Meir1, H Amital, Y Levy, A Kneller, Y Bar-Dayan, Y Shoenfeld.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a fatal disease characterized by widespread platelet aggregation, hemolytic anemia and fever with renal and neurological involvement. Different factors have been associated with the development of TTP, e.g. infections, pregnancy, chemotherapy, drug therapy and bone marrow transplantation. Recent data imply that all these different causes may induce the disease by decreasing the activity of the plasma von Willebrand factor-cleaving protease resulting in unusually large von Willebrand factor multimers that later on initiate the cascade of TTP. In this communication, we present a unique association between infection with Mycoplasma pneumoniae and TTP. We believe that the emergence of antibodies that cross-react with Mycoplasma and the protease might elucidate in this case the pathogenesis of TTP. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838456     DOI: 10.1159/000041030

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  12 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 2.  Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.

Authors:  Claudia Rizzo; Sergio Rizzo; Elisabetta Scirè; Danilo Di Bona; Carlo Ingrassia; Giovanni Franco; Roberto Bono; Gerlando Quintini; Calogero Caruso
Journal:  Blood Transfus       Date:  2012-06-27       Impact factor: 3.443

3.  Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection.

Authors:  Astrid Godron; Sabine Pereyre; Catherine Monet; Brigitte Llanas; Jérôme Harambat
Journal:  Pediatr Nephrol       Date:  2013-06-26       Impact factor: 3.714

4.  Thrombotic microangiopathy associated with Mycoplasma pneumoniae infection.

Authors:  Filipa Caeiro Alves; Rute Aguiar; Pedro Pessegueiro; Carlos Pires
Journal:  BMJ Case Rep       Date:  2018-03-17

5.  Systemic infections mimicking thrombotic thrombocytopenic purpura.

Authors:  Kristina K Booth; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

6.  Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.

Authors:  D Li; J Xiao; M Paessler; X L Zheng
Journal:  Thromb Haemost       Date:  2011-09-08       Impact factor: 5.249

Review 7.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness.

Authors:  Leo C James; Dan S Tawfik
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

Review 9.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

10.  Mycoplasma pneumoniae Epidemiology in England and Wales: A National Perspective.

Authors:  Rebecca J Brown; Patrick Nguipdop-Djomo; Hongxin Zhao; Elaine Stanford; O Brad Spiller; Victoria J Chalker
Journal:  Front Microbiol       Date:  2016-02-16       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.